{"nct_id":"NCT02905266","title":"A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma","status":"COMPLETED","status_verified_date":"2020-11","start_date":"2016-10-27","start_date_type":"ACTUAL","primary_completion_date":"2017-10-23","primary_completion_date_type":"ACTUAL","completion_date":"2019-10-25","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}